Type I Interferon Production Is Profoundly and Transiently Impaired in Primary HIV‐1 Infection
Author(s) -
Isabelle Kamga,
Sandrine Kahi,
Leyla Develioglu,
Miriam Lichtner,
Concepción Marañón,
Christiane Deveau,
Laurence Meyer,
Cécile Goujard,
Pierre Lebon,
Martine Sinet,
Anne Hosmalin
Publication year - 2005
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/430931
Subject(s) - peripheral blood mononuclear cell , immunology , viral load , interferon , multicenter aids cohort study , immune system , medicine , viral disease , virology , clinical endpoint , virus , lentivirus , immunopathology , herpes simplex virus , biology , antiretroviral therapy , clinical trial , in vitro , biochemistry
Successful immunological control of human immunodeficiency virus (HIV) infection is achieved only in rare individuals. Plasmacytoid dendritic cells (DCs) are mostly responsible for the production of strong antiviral factors--that is, type I interferons (IFNs)--in response to viruses. Their natural IFN production is impaired in chronic HIV infection, in correlation with viral load and disease progression, but it has not been tested during the critical stage of primary infection, when a balance is set between host immune responses and viral replication.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom